Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats

European Journal of Pharmacology

Volumn 702, Issue 1-3, 2013, Pages 25-31

  Reza Zarrindast, Mohammad ^a,b,c,d,e   Eslimi Esfahani, Delaram ^f   Oryan, Shahrbano ^f   Nasehi, Mohammad ^g   Torabi Nami, Mohammad ^e,h  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^e INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^f KHARAZMI UNIVERSITY   (Iran)

^g ISLAMIC AZAD UNIVERSITY   (Iran)

^h SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anxiety; Apomorphine; Cholestasis; Elevated plus maze; Rat(s); SCH23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; DEFECATION; DOPAMINERGIC SYSTEM; EXPLORATORY BEHAVIOR; GROOMING; HEPATIC ENCEPHALOPATHY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REARING;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHOLESTASIS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 84874049132     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.01.023     Document Type: Article

References (74)

1. S. Ahboucha, R.F. Butterworth, G. Pomier-Layrargues, C. Vincent, Z. Hassoun, and G.B. Baker Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C Neurogastroenterol. Motil. 20 2008 671 679
2. M. Anlauf, M.K. Schafer, L. Eiden, and E. Weihe Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes J. Comp. Neurol. 459 2003 90 111
3. J. Bearn, T. Allain, P. Coskeran, N. Munro, J. Butler, A. McGregor, and S. Wessely Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome Biol. Psychiatry 37 1995 245 252
4. N.V. Bergasa, D.W. Alling, J. Vergalla, and E.A. Jones Cholestasis in the male rat is associated with naloxone-reversible antinociception J. Hepatol. 20 1994 85 90
5. P.B. Bergqvist, B.A. Vogels, D.K. Bosman, M.A. Maas, S. Hjorth, R.A. Chamuleau, and F. Bengtsson Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt J. Neurochem. 64 1995 1238 1244
6. A.A. Borhani, G. Houshmand, M. Samini, K. Namiranian, A.R. Hajrasouliha, S. Tavakoli, F. Ebrahimi, and A.R. Dehpour alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids Eur. J. Pharmacol. 514 2005 183 189
7. A.W. Bruijnzeel kappa-Opioid receptor signaling and brain reward function Brain Res. Rev. 62 2009 127 146
8. K.W. Burak, T. Le, and M.G. Swain Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats Gastroenterology 122 2002 681 688
9. S. Cabib, E. Kempf, C. Schleef, A. Oliverio, and S. Puglisi-Allegra Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration Brain Res. 441 1988 153 160
10. M. Casarrubea, F. Sorbera, and G. Crescimanno Structure of rat behavior in hole-board: I) multivariate analysis of response to anxiety Physiol. Behav. 96 2009 174 179
11. O. Cauli, R. Rodrigo, M. Llansola, C. Montoliu, P. Monfort, B. Piedrafita, N. El Mlili, J. Boix, A. Agusti, and V. Felipo Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy Metab. Brain Dis. 24 2009 69 80
12. T. Celik, M.Z. Goren, K. Cinar, H. Gurdal, F.O. Onder, A. Tan, B. Terzioglu, A.M. Bozdayi, H. Bozkaya, O. Uzunalimoglu, and C. Yurdaydin Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat Hepatology 41 2005 731 737
13. C.H. Chung, C.H. Wang, C.Y. Tzen, and C.P. Liu Intrahepatic cholestasis as a paraneoplastic syndrome associated with pheochromocytoma J. Endocrinol. Invest. 28 2005 175 179
14. J.P. Colombo, C. Bachmann, H. Cervantes, M. Kokorovic, and R. Perritaz Tyrosine uptake and regional brain monoamine metabolites in a rat model resembling congenital hyperammonemia Pediatr. Res. 39 1996 1036 1040
15. A.R. Dehpour, N. Akbarloo, and P. Ghafourifar Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis Behav. Pharmacol. 9 1998 77 80
16. A.Y. Deutch, S.Y. Tam, and R.H. Roth Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra Brain Res. 333 1985 143 146
17. A.J. Dunn Stress-related activation of cerebral dopaminergic systems Ann NY Acad Sci. 537 1988 188 205
18. M.R. Ebrahimkhani, S. Kiani, F. Oakley, T. Kendall, A. Shariftabrizi, S.M. Tavangar, L. Moezi, S. Payabvash, A. Karoon, H. Hoseininik, D.A. Mann, K.P. Moore, A.R. Mani, and A.R. Dehpour Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats Gut 55 2006 1606 1616
19. D. Eslimi, S. Oryan, M. Nasehi, and M.R. Zarrindast Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats Eur. J. Pharmacol. 670 2011 180 185
20. M.G. Feenstra, M.H. Botterblom, and J.F. van Uum Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam Neurosci. Lett. 189 1995 81 84
21. P. Ferenci, D.F. Schafer, G. Kleinberger, J.H. Hoofnagle, and E.A. Jones Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease Lancet 2 1983 811 814
22. P. Ferenci, A. Lockwood, K. Mullen, R. Tarter, K. Weissenborn, and A.T. Blei Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 Hepatology 35 2002 716 721
23. D.M. Forton, N. Patel, M. Prince, A. Oatridge, G. Hamilton, J. Goldblatt, J.M. Allsop, J.V. Hajnal, H.C. Thomas, M. Bassendine, D.E. Jones, and S.D. Taylor-Robinson Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels Gut 53 2004 587 592
24. L.M. Garcia-Moreno, N.M. Conejo, H. Gonzalez-Pardo, M.A. Aller, M.P. Nava, J. Arias, and J.L. Arias Evaluation of two experimental models of hepatic encephalopathy in rats Braz. J. Med. Biol. Res. 38 2005 127 132
25. A.M. Garcia, R. Martinez, M.L. Brandao, and S. Morato Effects of apomorphine on rat behavior in the elevated plus-maze Physiol. Behav. 85 2005 440 447
26. P. Ghafourifar, A.R. Dehpour, and N. Akbarloo Inhibition by l-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis Life Sci. 60 1997 265 270 PL
27. S. Glaser, D. Alvaro, T. Roskams, J.L. Phinizy, G. Stoica, H. Francis, Y. Ueno, B. Barbaro, M. Marzioni, J. Mauldin, S. Rashid, M.G. Mancino, G. LeSage, and G. Alpini Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity Am. J. Physiol. Gastrointest. Liver Physiol. 284 2003 G683 694
28. S. Glaser, D. Alvaro, H. Francis, Y. Ueno, L. Marucci, A. Benedetti, S. De Morrow, M. Marzioni, M.G. Mancino, J.L. Phinizy, R. Reichenbach, G. Fava, R. Summers, J. Venter, and G. Alpini Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G813 826
29. R. Hadesman, R.H. Wiesner, V.L. Go, and G.M. Tyce Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathy J. Neurochem. 65 1995 1166 1175
30. P.E. Hayes, and S.C. Schulz The use of beta-adrenergic blocking agents in anxiety disorders and schizophrenia Pharmacotherapy 3 1983 101 117
31. L.T. Huang, M.M. Tiao, Y.L. Tain, C.C. Chen, and C.S. Hsieh Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats Pediatr. Res. 65 2009 176 180
32. L.T. Huang, C.C. Chen, J.M. Sheen, Y.J. Chen, C.S. Hsieh, and Y.L. Tain The interaction between high ammonia diet and bile duct ligation in developing rats: assessment by spatial memory and asymmetric dimethylarginine Int. J. Dev. Neurosci. 28 2010 169 174
33. A. Imperato, S. Puglisi-Allegra, A. Zocchi, M.G. Scrocco, P. Casolini, and L. Angelucci Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam Eur. J. Pharmacol. 175 1990 211 214
34. A.V. Kalueff, Y.R. Lou, I. Laaksi, and P. Tuohimaa Increased grooming behavior in mice lacking vitamin D receptors Physiol. Behav. 82 2004 405 409
35. G.F. Koob, and M. Le Moal Review. Neurobiological mechanisms for opponent motivational processes in addiction Philos. Trans. R. Soc. Lond. B Biol. Sci. 363 2008 3113 3123
36. G.D. LeSage, D. Alvaro, S. Glaser, H. Francis, L. Marucci, T. Roskams, J.L. Phinizy, M. Marzioni, A. Benedetti, S. Taffetani, B. Barbaro, G. Fava, Y. Ueno, and G. Alpini Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP Hepatology 40 2004 1116 1127
37. Z.S. Li, T.D. Pham, H. Tamir, J.J. Chen, and M.D. Gershon Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation J. Neurosci. 24 2004 1330 1339
38. Z.S. Li, C. Schmauss, A. Cuenca, E. Ratcliffe, and M.D. Gershon Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice J. Neurosci. 26 2006 2798 2807
39. A. Louilot, M. Le Moal, and H. Simon Differential reactivity of dopaminergic neurons in the nucleus accumbens in response to different behavioral situations. An in vivo voltammetric study in free moving rats Brain Res. 397 1986 395 400
40. Y.Y. Ma, L. Meng, C.Y. Guo, J.S. Han, D.Y. Lee, and C.L. Cui Dose- and time-dependent, context-induced elevation of dopamine and its metabolites in the nucleus accumbens of morphine-induced CPP rats Behav. Brain Res. 204 2009 192 199
41. I. Magen, Y. Avraham, Z. Ackerman, L. Vorobiev, R. Mechoulam, and E.M. Berry Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation Br. J. Pharmacol. 159 2010 950 957
42. J.K. Mallajosyula, D. Kaur, S.J. Chinta, S. Rajagopalan, A. Rane, D.G. Nicholls, D.A. Di Monte, H. Macarthur, and J.K. Andersen MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology PLoS One 3 2008 e1616
43. M. Mendez, M. Mendez-Lopez, L. Lopez, M.A. Aller, J. Arias, and J.L. Arias Associative learning deficit in two experimental models of hepatic encephalopathy Behav. Brain Res. 198 2009 346 351
44. M. Narita, Y. Matsushima, K. Niikura, S. Takagi, K. Nakahara, K. Kurahashi, M. Abe, M. Saeki, M. Asato, S. Imai, K. Ikeda, N. Kuzumaki, and T. Suzuki Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in mu-opioid-induced place preference Addict. Biol. 15 2010 434 447
45. M. Nasehi, F. Mafi, S. Oryan, S. Nasri, and M.R. Zarrindast The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response Pharmacol. Biochem. Behav. 98 2011 468 473
46. J.L. Newton Fatigue in primary biliary cirrhosis Clin. Liver Dis. 12 2008 367 383 ix
47. H. Nguyen, H. Wang, T. le, W. Ho, K.A. Sharkey, and M.G. Swain Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats Neurogastroenterol. Motil. 20 2008 228 235
48. S. Nikolaus, C. Antke, M. Beu, and H.W. Muller Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders - results from in vivo imaging studies Rev. Neurosci. 21 2010 119 139
49. R. Noyes Jr. Beta-adrenergic blocking drugs in anxiety and stress Psychiatr. Clin. North Am. 8 1985 119 132
50. K. Ohara, M. Aoyama, M. Fujita, K. Sobue, and K. Asai Prolonged exposure to ammonia increases extracellular glutamate in cultured rat astrocytes Neurosci. Lett. 462 2009 109 112
51. K. Pi-Chieh Wang, L.M. Lee, T.J. Lin, S.M. Sheen-Chen, J.W. Lin, W.T. Chiu, C.C. Wang, and K.S. Hung Gene transfer of IGF1 attenuates hepatocellular apoptosis after bile duct ligation J. Surg. Res. 167 2011 237 244
52. S. Puglisi-Allegra, A. Imperato, L. Angelucci, and S. Cabib Acute stress induces time-dependent responses in dopamine mesolimbic system Brain Res. 554 1991 217 222
53. A.K. Radke, P.E. Rothwell, and J.C. Gewirtz An anatomical basis for opponent process mechanisms of opiate withdrawal J. Neurosci. 31 2011 7533 7539
54. J.F. Reinhard Jr., M.J. Bannon, and R.H. Roth Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam Naunyn Schmiedebergs Arch. Pharmacol. 318 1982 374 377
55. A. Rezayof, S.S. Hosseini, and M.R. Zarrindast Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors Behav. Brain Res. 202 2009 171 178
56. S.M. Roberts, N.P. Skoulis, and R.C. James A centrally-mediated effect of morphine to diminish hepatocellular glutathione Biochem. Pharmacol. 36 1987 3001 3005
57. S.C. Sealfon, and C.W. Olanow Dopamine receptors: from structure to behavior Trends Neurosci. 23 2000 S34 40
58. A.C. Sundewall, and A.K. Lefvert Acetylcholine receptor antibodies in primary biliary cirrhosis: characterization of antigen and idiotypic specificity Scand. J. Immunol. 31 1990 477 484
59. M.G. Swain, V. Patchev, J. Vergalla, G. Chrousos, and E.A. Jones Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis J. Clin. Invest. 91 1993 1903 1908
60. M.G. Swain, R.B. Rothman, H. Xu, J. Vergalla, N.V. Bergasa, and E.A. Jones Endogenous opioids accumulate in plasma in a rat model of acute cholestasis Gastroenterology 103 1992 630 635
61. A.N. Talaenko, G.K. Krivobok, D.V. Pankrat'ev, and N.V. Goncharenko Neurochemical mechanisms of dorsal pallidum in antiadverse effects of anxiolytics of different models of anxiety Ross. Fiziol. Zh. Im. I. M. Sechenova 91 2005 776 784
62. J.R. Thornton, and M.S. Losowsky Opioid peptides and primary biliary cirrhosis BMJ 297 1988 1501 1504
63. C. Wikell, P.B. Bergqvist, S. Hjorth, G. Apelqvist, H. Bjork, and F. Bengtsson Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy Clin. Neuropharmacol. 21 1998 296 306
64. C. Yurdaydin, H. Hortnagl, P. Steindl, C. Zimmermann, C. Pifl, E.A. Singer, E. Roth, and P. Ferenci Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure Hepatology 12 1990 695 700
65. M.R. Zarrindast, and A. Rezayof Morphine state-dependent learning: sensitization and interactions with dopamine receptors Eur. J. Pharmacol. 497 2004 197 204
66. M.R. Zarrindast, S. Hoseindoost, and M. Nasehi Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice Behav. Brain Res. 228 2012 116 124
67. M.R. Zarrindast, S. Hoseindoost, and M. Nasehi Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice Behav. Brain Res. 228 2012 116 124
68. M.R. Zarrindast, M. Bananej, A. Khalilzadeh, S. Fazli-Tabaei, A. Haeri-Rohani, and A. Rezayof Influence of intracerebroventricular administration of dopaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test Neurobiol. Learn Mem. 86 2006 286 292
69. M.R. Zarrindast, N. Naghdi-Sedeh, M. Nasehi, H. Sahraei, F. Bahrami, and F. Asadi The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response Neurosci. Lett. 475 2010 156 160
70. M.R. Zarrindast, S. Khalifeh, A. Rezayof, P. Rostami, A. Aghamohammadi Sereshki, and M. Zahmatkesh Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors Brain Res. 1460 2012 25 32
71. M.L. Zeneroli, M. Baraldi, E. Ventura, C. Vezzelli, O. Tofanetti, M. Germini, and I. Casciarri Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy Life Sci. 48 1991 37 50
72. Y. Zhang, J.Y. Hong, C.E. Rockwell, B.L. Copple, H. Jaeschke, and C.D. Klaassen Effect of bile duct ligation on bile acid composition in mouse serum and liver Liver Int. 32 2012 58 69
73. Y.T. Zhang, Q.S. Zheng, J. Pan, and R.L. Zheng Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants Basic Clin. Pharmacol. Toxicol. 95 2004 53 58
74. S.M. Zimatkin, O.V. Baraban, and S.V. Emel'yanchik Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis Neurosci. Behav. Physiol. 38 2008 807 810